Target intelligence / Profile preview

STAM divergent transcript (STAM-DT)

Target
STAM-DT
Molecular classification
Other (long noncoding RNA, lncRNA)
01

Overview

STAM divergent transcript (STAM-DT), also known as STAM antisense RNA 1 (head to head), STAM-AS1, and locus3182, is a long noncoding RNA (lncRNA) gene transcribed divergently from the promoter of the STAM protein-coding gene[4][3]. Divergent transcription refers to the phenomenon where both coding and noncoding transcripts initiate in opposite directions from shared promoters, and is a widespread feature of mammalian genome regulation[1][3]. At the STAM-DT locus, two alternatively spliced lncRNA transcripts are generated in the orientation opposite to the STAM gene[3]. These lncRNAs are generally less stable and are subject to exosome-mediated degradation, although in some cases they can accumulate to detectable levels and may participate in the regulation of their sense (protein-coding) partner or aspects of cell differentiation[3]. There is no evidence that STAM-DT functions as a receptor, enzyme, or therapeutic target, and interacting drugs or biomarker roles have not been established. Its precise biological or disease roles are poorly characterized, typical for many noncoding RNAs generated by divergent transcription in the genome[2][3][4].

Other names
STAM-AS1locus3182locus 3182STAM antisense RNA 1 (head to head)STAM-DT
02

Biological functions

Regulation of gene expressionRegulation of molecular functionPossible involvement in cell state/differentiation
03

Disease associations

Other (No explicitly established role in disease; possible implication in gene regulation and cellular differentiation, but not a validated disease gene)

Beyond the preview

Go deeper on STAM divergent transcript (STAM-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAM divergent transcript (STAM-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call